Drug Shortage Report for JANUMET XR
Report ID | 150734 |
Drug Identification Number | 02416794 |
Brand name | JANUMET XR |
Common or Proper name | sitagliptin and metformin hydrochloride modified-release tablets |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
Strength(s) | 1000MG 50MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-12-07 |
Estimated end date | 2021-12-13 |
Actual end date | 2021-12-13 |
Shortage status | Resolved |
Updated date | 2021-12-14 |
Company comments | Shortage due to quality testing delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-12-14 | English | Compare |
v4 | 2021-12-13 | French | Compare |
v3 | 2021-12-13 | English | Compare |
v2 | 2021-12-08 | French | Compare |
v1 | 2021-12-08 | English | Compare |
Showing 1 to 5 of 5